These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19076537)

  • 1. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy.
    Martínez-Gómez JM; Johansen P; Rose H; Steiner M; Senti G; Rhyner C; Crameri R; Kündig TM
    Allergy; 2009 Jan; 64(1):172-8. PubMed ID: 19076537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
    J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.
    Zaleska A; Eiwegger T; Soyer O; van de Veen W; Rhyner C; Soyka MB; Bekpen C; Demiröz D; Treis A; Söllner S; Palomares O; Kwok WW; Rose H; Senti G; Kündig TM; Ozoren N; Jutel M; Akdis CA; Crameri R; Akdis M
    Allergy; 2014 Sep; 69(9):1162-70. PubMed ID: 24934402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy.
    Grundström J; Neimert-Andersson T; Kemi C; Nilsson OB; Saarne T; Andersson M; van Hage M; Gafvelin G
    Int Arch Allergy Immunol; 2012; 157(2):136-46. PubMed ID: 21985799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The major cat allergen, Fel d 1, in diagnosis and therapy.
    Grönlund H; Saarne T; Gafvelin G; van Hage M
    Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy.
    Worm M; Lee HH; Kleine-Tebbe J; Hafner RP; Laidler P; Healey D; Buhot C; Verhoef A; Maillère B; Kay AB; Larché M
    J Allergy Clin Immunol; 2011 Jan; 127(1):89-97, 97.e1-14. PubMed ID: 21211644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of hypoallergens applied to the major cat allergen Fel d 1.
    Saarne T; Kaiser L; Grönlund H; Rasool O; Gafvelin G; van Hage-Hamsten M
    Clin Exp Allergy; 2005 May; 35(5):657-63. PubMed ID: 15898990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralymphatic injections as a new administration route for allergen-specific immunotherapy.
    Martínez-Gómez JM; Johansen P; Erdmann I; Senti G; Crameri R; Kündig TM
    Int Arch Allergy Immunol; 2009; 150(1):59-65. PubMed ID: 19339803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IVN201--therapy with a construct containing functional fusion peptides.
    Rose H
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():319-27; discussion 327-8. PubMed ID: 20799476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy.
    Morales M; Gallego M; Iraola V; Taulés M; de Oliveira E; Moya R; Carnés J
    BMC Immunol; 2017 Feb; 18(1):10. PubMed ID: 28235411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects.
    Mark PG; Segal DB; Dallaire ML; Garman RD
    Clin Exp Allergy; 1996 Nov; 26(11):1316-28. PubMed ID: 8955581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.
    Schmitz N; Dietmeier K; Bauer M; Maudrich M; Utzinger S; Muntwiler S; Saudan P; Bachmann MF
    J Exp Med; 2009 Aug; 206(9):1941-55. PubMed ID: 19667059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Shamji MH; Singh I; Layhadi JA; Ito C; Karamani A; Kouser L; Sharif H; Tang J; Handijiev S; Parkin RV; Durham SR; Kostic A; Orengo JM; DeVeaux M; Kamal M; Stahl N; Yancopoulos GD; Wang CQ; Radin AR
    Am J Respir Crit Care Med; 2021 Jul; 204(1):23-33. PubMed ID: 33651675
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats.
    Pène J; Desroches A; Paradis L; Lebel B; Farce M; Nicodemus CF; Yssel H; Bousquet J
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):571-8. PubMed ID: 9802364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with a Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy.
    Saarne T; Neimert-Andersson T; Grönlund H; Jutel M; Gafvelin G; van Hage M
    Allergy; 2011 Feb; 66(2):255-63. PubMed ID: 20804464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines.
    Crameri R; Flückiger S; Daigle I; Kündig T; Rhyner C
    Allergy; 2007 Feb; 62(2):197-206. PubMed ID: 17298430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.
    Ewbank PA; Murray J; Sanders K; Curran-Everett D; Dreskin S; Nelson HS
    J Allergy Clin Immunol; 2003 Jan; 111(1):155-61. PubMed ID: 12532112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of an allergen in dog dander that cross-reacts with the major cat allergen, Fel d 1.
    Reininger R; Varga EM; Zach M; Balic N; Lindemeier AD; Swoboda I; Grönlund H; van Hage M; Rumpold H; Valenta R; Spitzauer S
    Clin Exp Allergy; 2007 Jan; 37(1):116-24. PubMed ID: 17210049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric human-cat Fcgamma-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen.
    Terada T; Zhang K; Belperio J; Londhe V; Saxon A
    Clin Immunol; 2006 Jul; 120(1):45-56. PubMed ID: 16473552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS.
    Niespodziana K; Focke-Tejkl M; Linhart B; Civaj V; Blatt K; Valent P; van Hage M; Grönlund H; Valenta R
    J Allergy Clin Immunol; 2011 Jun; 127(6):1562-70.e6. PubMed ID: 21411130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.